Contract manufacturing & logistics

Biopharma causes Cambrex bleed

Biopharma causes Cambrex bleed

By Gregory Roumeliotis

Life sciences firm Cambrex has reported a $140.3m (€116.7m) loss in
Q4 as opposed to a profit of $4.9m in Q4 last year, hit by lower
long-term profitability projections for its Biopharma unit, as
biotech companies seem to lose their...

Ometric speeds QC up

Ometric speeds QC up

By Gregory Roumeliotis

Analytic technology company Ometric is promising to revolutionalise
quality control with software that achieves real-time, in-line
final product testing at a rate of five tablets per second,
minimising product recalls, reducing waste...

Brecon doubles its UK site

Brecon doubles its UK site

By Gregory Roumeliotis

Commercial packaging and clinical trials services provider Brecon
Pharmaceuticals has completed the doubling in size of its facility
in Hereford, responding to growing demands from its pharmaceutical
customers.

Follow us

Products

View more

Webinars